Sungwun
1 known investors
Sungwun Pharmacopia develops active pharmaceutical ingredients (APIs) and biopharmaceutical drugs, including antiviral compounds such as remdesivir and favipiravir, which it manufactures and licenses to pharmaceutical partners. The company also works on microbiome-related technology and has partnered with Indonesian pharmaceutical firm PT. Kimia Farma.
Investors · 1
Frequently asked questions
- What does Sungwun do?
- Sungwun Pharmacopia develops active pharmaceutical ingredients (APIs) and biopharmaceutical drugs, including antiviral compounds such as remdesivir and favipiravir, which it manufactures and licenses to pharmaceutical partners. The company also works on microbiome-related technology and has partnered with Indonesian pharmaceutical firm PT. Kimia Farma.
- Who are Sungwun's investors?
- Sungwun's investors include Aju IB Invesment Corporation.